Alicia Grande - 28 Mar 2023 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
VP, Treasurer and CFO
Signature
/s/ Alicia Grande
Issuer symbol
CPRX
Transactions as of
28 Mar 2023
Net transactions value
-$1,695,395
Form type
4
Filing time
30 Mar 2023, 17:00:51 UTC
Previous filing
24 Mar 2023
Next filing
12 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $45,991 +58,216 +115% $0.7900* 108,773 28 Mar 2023 Direct
transaction CPRX Common stock, par value $0.001 per share Sale $468,386 -28,216 -26% $16.60 80,557 28 Mar 2023 Direct F1
transaction CPRX Common stock, par value $0.001 per share Sale $165,500 -10,000 -12% $16.55 70,557 28 Mar 2023 Direct F1
transaction CPRX Common stock, par value $0.001 per share Sale $165,200 -10,000 -14% $16.52 60,557 28 Mar 2023 Direct F1
transaction CPRX Common stock, par value $0.001 per share Sale $163,700 -10,000 -17% $16.37 50,557 28 Mar 2023 Direct F1
transaction CPRX Common stock, par value $0.001 per share Options Exercise $56,500 +50,000 +99% $1.13* 100,557 29 Mar 2023 Direct
transaction CPRX Common stock, par value $0.001 per share Sale $334,400 -20,000 -20% $16.72 80,557 29 Mar 2023 Direct F1
transaction CPRX Common stock, par value $0.001 per share Sale $334,000 -20,000 -25% $16.70 60,557 29 Mar 2023 Direct F1
transaction CPRX Common stock, par value $0.001 per share Sale $166,700 -10,000 -17% $16.67 50,557 29 Mar 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -58,216 -4.1% $0.000000 1,345,834 28 Mar 2023 Common Stock 58,216 $0.7900 Direct F2
transaction CPRX Options to purchase common stock Options Exercise $0 -50,000 -3.7% $0.000000 1,295,834 29 Mar 2023 Common Stock 50,000 $1.13 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold to cover exercise price of options, tax withholding requirements and for personal reasons. Shares were not sold as a result of any disagreement with the Company and Ms. Grande remains an officer of the Company.
F2 Options vested in two annual tranches beginning on June 15, 2017.
F3 Options vested in three annual tranches beginning on January 3, 2018.